Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 Diabetes
Author:
Affiliation:
1. Profil, Neuss, Germany
2. Novo Nordisk A/S, Søborg, Denmark
3. Atlanta Diabetes Associates, Atlanta, GA, USA
Funder
Novo Nordisk
Publisher
SAGE Publications
Subject
Biomedical Engineering,Bioengineering,Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
http://journals.sagepub.com/doi/pdf/10.1177/1932296817730375
Reference17 articles.
1. Continuous subcutaneous insulin infusion in diabetes: patient populations, safety, efficacy, and pharmacoeconomics
2. Moving toward the ideal insulin for insulin pumps
3. Faster‐acting insulin aspart: earlier onset of appearance and greater early pharmacokinetic and pharmacodynamic effects than insulin aspart
4. Pharmacological properties of faster-acting insulin aspart vs insulin aspart in patients with type 1 diabetes receiving continuous subcutaneous insulin infusion: A randomized, double-blind, crossover trial
Cited by 47 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Ultrafast-acting insulin: pharmacological properties and their impact on clinical aspects;Meditsinskiy sovet = Medical Council;2024-09-02
2. Are New Ultra-Rapid-Acting Insulins Associated with Improved Glycemic Control and Reduced Hypoglycemia in Comparison to Conventional Rapid-Acting Insulins for Individuals with Type 1 and Type 2 Diabetes? A Systematic Review and Meta-Analysis;Diabetes Technology & Therapeutics;2024-08-01
3. Analogues ultra-rapides de l’insuline et délivrance automatisée de l’insuline, un réel pas en avant ?;Médecine des Maladies Métaboliques;2024-06
4. Results of biosimilar assessing of insulin aspart preparations of Russian and foreign production using the hyperinsulinemic euglycemic clamp method and studying the use of a new ultra-fast-acting Russian biosimilar in pumps;Meditsinskiy sovet = Medical Council;2024-02-26
5. The Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert Consensus;Journal of Diabetes Science and Technology;2023-11-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3